GL1X · GenesisL1 explorer

MolNFT v1 · #137017 · protein

Il-17A in complex with peptide

5VB9 · Interleukin-17A: “Il-17A in complex with peptide”. X-ray diffraction, 1 ligand (CL), 3 pockets (best druggability 0.56). MolNFT v1 #137017 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5VB9
Type
protein
Length
239 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Interleukin-17A; Peptide inhibitor
UniProt
Q16552
Ligands
CL
Pockets
3 · best druggability 0.56

Structure

x-ray diffraction · 3 distinct chains · 4% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInterleukin-17Aprotein1084% helix, 45% strandQ16552
BInterleukin-17Aprotein1014% helix, 49% strandQ16552
C, DPeptide inhibitorprotein150% helix, 40% strand—

Ligands and binding sites

  • CL · Chloride ion · ion · chains B
  • EDO · 1,2-ethanediol · additive · 3 copies · chains A, C, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13690.560.7433empty
2930.480.8119empty
3990.460.7919empty

Interfaces

3 interfaces between chains.

  • B–D · 563 Ų buried · 6 hydrogen bonds · protein-protein
  • A–C · 551 Ų buried · 5 hydrogen bonds · protein-protein
  • A–B · 206 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 5VB9 · IL-17A in complex with peptide · the same entry in another collection · chain A against A, TM-score 1.00
  • Q16552 · AlphaFold monomer V2.0 prediction for interleukin-17A (Q16552) · a predicted model of the same protein · chain B against A, TM-score 0.85

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.